146 related articles for article (PubMed ID: 7541934)
1. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.
Ross JS; Nazeer T; Figge HL; Fisher HA; Rifkin MD
Am J Clin Pathol; 1995 Jul; 104(1):36-41. PubMed ID: 7541934
[TBL] [Abstract][Full Text] [Related]
2. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
[TBL] [Abstract][Full Text] [Related]
3. Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer.
Pollack A; Zagars GK; el-Naggar AK; Terry NH
Urology; 1994 Nov; 44(5):711-8. PubMed ID: 7526527
[TBL] [Abstract][Full Text] [Related]
4. Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade.
Kleer E; Larson-Keller JJ; Zincke H; Oesterling JE
Urology; 1993 Mar; 41(3):207-16. PubMed ID: 7680176
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin D and epidermal growth factor receptor immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy.
Moul JW; Maygarden SJ; Ware JL; Mohler JL; Maher PD; Schenkman NS; Ho CK
J Urol; 1996 Mar; 155(3):982-5. PubMed ID: 8583622
[TBL] [Abstract][Full Text] [Related]
6. Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease.
Carmichael MJ; Veltri RW; Partin AW; Miller MC; Walsh PC; Epstein JI
J Urol; 1995 Mar; 153(3 Pt 2):1015-9. PubMed ID: 7853549
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
Zagars GK; Pollack A; von Eschenbach AC
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin D cytosolic assay and immunohistochemical quantification in human prostate tumors.
Chambon M; Rebillard X; Rochefort H; Brouillet JP; Baldet P; Guiter J; Maudelonde T
Prostate; 1994 Jun; 24(6):320-5. PubMed ID: 7516070
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric DNA analysis of fresh prostatic resections. Correlation with conventional prognostic parameters in patients with prostate cancer.
Hussain MH; Powell I; Zaki N; Maciorowski Z; Sakr W; KuKuruga M; Visscher D; Haas GP; Pontes JE; Ensley JF
Cancer; 1993 Nov; 72(10):3012-9. PubMed ID: 7693326
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer.
Badalament RA; O'Toole RV; Young DC; Drago JR
Cancer; 1991 Jun; 67(12):3014-23. PubMed ID: 1710533
[TBL] [Abstract][Full Text] [Related]
12. DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma.
Berner A; Waere H; Nesland JM; Paus E; Danielsen HE; Fosså SD
Br J Urol; 1995 Jan; 75(1):26-32. PubMed ID: 7531589
[TBL] [Abstract][Full Text] [Related]
13. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy.
Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG
Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048
[TBL] [Abstract][Full Text] [Related]
14. Serum prostate-specific antigen and the biologic progression of prostate cancer.
Kabalin JN; McNeal JE; Johnstone IM; Stamey TA
Urology; 1995 Jul; 46(1):65-70. PubMed ID: 7541589
[TBL] [Abstract][Full Text] [Related]
15. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
[TBL] [Abstract][Full Text] [Related]
16. DNA in radical prostatectomy specimens. Prognostic value of tumor ploidy.
Robertson CN; Paulson DF
Acta Oncol; 1991; 30(2):205-7. PubMed ID: 2029406
[TBL] [Abstract][Full Text] [Related]
17. Pre- and postoperative DNA ploidy patterns correlated to pT-stage, histological grade and tumour volume in total prostatectomy specimens.
Häggman M; de la Torre M; Brändstedt S; Norlén BJ; Norberg M; Busch C
Scand J Urol Nephrol; 1994 Mar; 28(1):59-66. PubMed ID: 8009195
[TBL] [Abstract][Full Text] [Related]
18. Histologic grade, DNA ploidy, and intraglandular tumor extent as indicators of tumor progression of clinical stage B prostatic carcinoma. A direct comparison.
Humphrey PA; Walther PJ; Currin SM; Vollmer RT
Am J Surg Pathol; 1991 Dec; 15(12):1165-70. PubMed ID: 1746683
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of DNA quantitation in stage D1 prostate carcinoma with the use of image analysis.
Peters-Gee JM; Miles BJ; Cerny JC; Gaba AR; Jacobsen G; Crissman JD
Cancer; 1992 Sep; 70(5):1159-65. PubMed ID: 1515991
[TBL] [Abstract][Full Text] [Related]
20. Pathologic parameters and flow cytometric ploidy analysis in predicting recurrence in carcinoma of the prostate.
Voges GE; Eigner EB; Ross W; Sussman H; Stöckle M; Freiha FS; Stamey TA
Eur Urol; 1993; 24(1):132-9. PubMed ID: 8365433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]